Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated:  7/24/2014
Paddington Testing Company
mi
from
Philadelphia, PA
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Paddington Testing Company
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated:  7/24/2014
AllCare Foot & Ankle, PA
mi
from
Arlington, TX
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
AllCare Foot & Ankle, PA
mi
from
Arlington, TX
Click here to add this to my saved trials
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated:  7/24/2014
Coastal Podiatry Group
mi
from
Virginia Beach, VA
Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers
Open Label Trial of Topical PluroGel PN for the Treatment of Patients With Mildly Infected Diabetic Foot Ulcer CLINICAL PROTOCOL PGN-1300X
Status: Enrolling
Updated: 7/24/2014
Coastal Podiatry Group
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers
A Multi-Center, Prospective, Cohort Trial Comparing the Effectiveness of AutoloGel Therapy to Usual and Customary Care in All Wagner Grades of Diabetic Foot Ulcers
Status: Enrolling
Updated:  7/28/2014
Clinical Research Facility
mi
from
Arcadia, CA
Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers
A Multi-Center, Prospective, Cohort Trial Comparing the Effectiveness of AutoloGel Therapy to Usual and Customary Care in All Wagner Grades of Diabetic Foot Ulcers
Status: Enrolling
Updated: 7/28/2014
Clinical Research Facility
mi
from
Arcadia, CA
Click here to add this to my saved trials
Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers
A Multi-Center, Prospective, Cohort Trial Comparing the Effectiveness of AutoloGel Therapy to Usual and Customary Care in All Wagner Grades of Diabetic Foot Ulcers
Status: Enrolling
Updated:  7/28/2014
HyperBarxs at Northside Forsyth
mi
from
Cumming, GA
Effectiveness of AutoloGel Therapy in Diabetic Foot Ulcers
A Multi-Center, Prospective, Cohort Trial Comparing the Effectiveness of AutoloGel Therapy to Usual and Customary Care in All Wagner Grades of Diabetic Foot Ulcers
Status: Enrolling
Updated: 7/28/2014
HyperBarxs at Northside Forsyth
mi
from
Cumming, GA
Click here to add this to my saved trials
Gut Hormone Profiling in Obese Patients With Type 2 Diabetes (MK-0000-134)
Gut Hormone Profiling in Peripheral Blood After Bariatric Surgery in Obese Patients With Type 2 Diabetes
Status: Enrolling
Updated:  7/31/2014
Clinical Research Facility
mi
from
Indianapolis, IN
Gut Hormone Profiling in Obese Patients With Type 2 Diabetes (MK-0000-134)
Gut Hormone Profiling in Peripheral Blood After Bariatric Surgery in Obese Patients With Type 2 Diabetes
Status: Enrolling
Updated: 7/31/2014
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/31/2014
Clinical Research Facility
mi
from
Anaheim, CA
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/31/2014
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/31/2014
Clinical Research Facility
mi
from
DeLand, FL
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/31/2014
Clinical Research Facility
mi
from
DeLand, FL
Click here to add this to my saved trials
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/31/2014
Clinical Research Facility
mi
from
South Miami, FL
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/31/2014
Clinical Research Facility
mi
from
South Miami, FL
Click here to add this to my saved trials
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  7/31/2014
Clinical Research Facility
mi
from
St. Paul, MN
Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Participants With Type 2 Diabetes Mellitus (MK-8835-009)
A Phase 1, Non-Randomized, Open-Label, Single Dose Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 7/31/2014
Clinical Research Facility
mi
from
St. Paul, MN
Click here to add this to my saved trials
Nepafenac Once Daily for Macular Edema - Study 2
Randomized, Double-Masked, Vehicle Controlled, Clinical Evaluation To Assess The Safety And Efficacy Of Nepafenac Ophthalmic Suspension, 0.3% For Improvement In Clinical Outcomes Among Diabetic Subjects Following Cataract Surgery
Status: Enrolling
Updated:  8/8/2014
Alcon Call Center
mi
from
Fort Worth, TX
Nepafenac Once Daily for Macular Edema - Study 2
Randomized, Double-Masked, Vehicle Controlled, Clinical Evaluation To Assess The Safety And Efficacy Of Nepafenac Ophthalmic Suspension, 0.3% For Improvement In Clinical Outcomes Among Diabetic Subjects Following Cataract Surgery
Status: Enrolling
Updated: 8/8/2014
Alcon Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Sensor-based Balance Training in Diabetes: A Virtual Reality Paradigm
Game-Based Virtual Reality Approach for Improving Balance, Reducing Falls, and Preventing Complications In Diabetes
Status: Enrolling
Updated:  8/11/2014
University Medical Center
mi
from
Tucson, AZ
Sensor-based Balance Training in Diabetes: A Virtual Reality Paradigm
Game-Based Virtual Reality Approach for Improving Balance, Reducing Falls, and Preventing Complications In Diabetes
Status: Enrolling
Updated: 8/11/2014
University Medical Center
mi
from
Tucson, AZ
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Phoenix, AZ
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Little Rock, AR
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Little Rock, AR
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Chino, CA
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Chino, CA
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Concord, CA
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Concord, CA
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Escondido, CA
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Escondido, CA
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Fresno, CA
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Fresno, CA
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
San Mateo, CA
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
San Mateo, CA
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
San Ramon, CA
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
San Ramon, CA
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Walnut Creek, CA
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Aurora, CO
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Aurora, CO
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Golden, CO
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Golden, CO
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Maitland, FL
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Maitland, FL
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Atlanta, GA
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Marietta, GA
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Marietta, GA
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Roswell, GA
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Roswell, GA
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Champaign, IL
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Champaign, IL
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Chicago, IL
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Chicago, IL
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Skokie, IL
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Skokie, IL
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Council Bluffs, IA
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Council Bluffs, IA
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Lexington, KY
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Lexington, KY
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Rockville, MD
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Rockville, MD
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Minneapolis, MN
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Chesterfield, MO
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Chesterfield, MO
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Billings, MT
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Billings, MT
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Butte, MT
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Butte, MT
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Albany, NY
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Albany, NY
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Jamaica, NY
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Jamaica, NY
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Staten Island, NY
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Staten Island, NY
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Durham, NC
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Durham, NC
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Morehead City, NC
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Morehead City, NC
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Wilmington, NC
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Wilmington, NC
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Fargo, ND
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Fargo, ND
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Bristol, TN
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Bristol, TN
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Chattanooga, TN
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Chattanooga, TN
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Amarillo, TX
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Amarillo, TX
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Austin, TX
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Austin, TX
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Austin, TX
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Austin, TX
Click here to add this to my saved trials
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated:  8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Dallas, TX
The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes
A 26-weeks Randomised, Insulin Capped, Placebo-controlled, Double-blind, Parallel Group, Multinational, Multi-centre Trial
Status: Enrolling
Updated: 8/14/2014
Novo Nordisk Clinical Trial Call Center
mi
from
Dallas, TX
Click here to add this to my saved trials